Codexis Inc (CDXS)

Dec 20, 2024

BNP Paribas Financial Markets Trims Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Dec 20, 2024

Dec 19, 2024

Codexis (NASDAQ:CDXS) Stock Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat

Dec 19, 2024

Dec 17, 2024

Codexis's SWOT analysis: enzymatic pioneer's stock poised for RNAi revolution - Investing.com India

Dec 17, 2024

Dec 16, 2024

Codexis's SWOT analysis: enzymatic pioneer's stock poised for RNAi revolution By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 14, 2024

Codexis, Inc.'s (NASDAQ:CDXS) high institutional ownership speaks for itself as stock continues to impress, up 17% over last week - Yahoo Finance

Dec 14, 2024

Dec 10, 2024

Is Codexis (NASDAQ:CDXS) Using Debt In A Risky Way? - Simply Wall St

Dec 10, 2024

Dec 08, 2024

Jacobs Levy Equity Management Inc. Decreases Stock Holdings in Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Dec 08, 2024

Dec 06, 2024

Codexis Announces New Employment Inducement Grants - The Manila Times

Dec 06, 2024

Dec 06, 2024

Codexis Awards Strategic Equity Package: 208K Shares in Options and RSUs for Key New Hires - StockTitan

Dec 06, 2024

Dec 05, 2024

Codexis stock soars to 52-week high, touches $4.92 By Investing.com - Investing.com Canada

Dec 05, 2024

Dec 04, 2024

Codexis stock soars to 52-week high, touches $4.92 - Investing.com India

Dec 04, 2024

Dec 04, 2024

Global Artificial Sweeteners Market to Observe Growth at a CAGR of ~4% by 2030 | DelveInsight - GlobeNewswire Inc.

Dec 04, 2024

Dec 02, 2024

Codexis, Inc. (NASDAQ:CDXS) Shares Sold by Fred Alger Management LLC - MarketBeat

Dec 02, 2024

Dec 01, 2024

Codexis, Inc. (NASDAQ:CDXS) Sees Large Decrease in Short Interest - MarketBeat

Dec 01, 2024

Nov 26, 2024

Cantor Fitzgerald Reaffirms “Overweight” Rating for Codexis (NASDAQ:CDXS) - Defense World

Nov 26, 2024

Nov 26, 2024

Codexis's SWOT analysis: enzymatic platform poised to shake up RNAi stock - Investing.com

Nov 26, 2024

Nov 23, 2024

Codexis (NASDAQ:CDXS) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat

Nov 23, 2024

Nov 23, 2024

GSA Capital Partners LLP Grows Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Nov 23, 2024

Nov 22, 2024

Deep Dive Into Codexis Stock: Analyst Perspectives (4 Ratings) - Benzinga

Nov 22, 2024

Nov 22, 2024

Codexis (STU:4QK) EBITDA per Share : €-0.40 (TTM As of Sep. 2024) - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

Codexis (STU:4QK) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 21, 2024

Codexis (STU:4QK) 3-Year FCF Growth Rate : -35.00% (As of Sep. 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

Codexis (STU:4QK) Forward Dividend Yield % : 0.00% (As of Nov. 20, 2024) - GuruFocus.com

Nov 20, 2024

Nov 20, 2024

Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Nov 20, 2024

Nov 19, 2024

Codexis to Present at Piper Sandler Healthcare Conference in December 2024 | CDXS Stock News - StockTitan

Nov 19, 2024

Nov 15, 2024

Codexis (NASDAQ:CDXS) Given Overweight Rating at Cantor Fitzgerald - MarketBeat

Nov 15, 2024

Nov 14, 2024

Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics - GlobeNewswire

Nov 14, 2024

Nov 14, 2024

Codexis Achieves 98% Efficiency in Breakthrough siRNA Synthesis Platform | CDXS Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Baillie Gifford & Co. Sells 895,002 Shares of Codexis, Inc. (NASDAQ:CDXS) - MarketBeat

Nov 14, 2024

Nov 13, 2024

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors - The Manila Times

Nov 13, 2024

Nov 12, 2024

Codexis adds biotech veteran Raymond De Vré to board - Investing.com India

Nov 12, 2024

Nov 12, 2024

Codexis Strengthens Board and Updates Bylaws - TipRanks

Nov 12, 2024

Nov 12, 2024

CDXSCodexis, Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024

Nov 12, 2024

Codexis adds biotech veteran Raymond De Vré to board By Investing.com - Investing.com UK

Nov 12, 2024

Nov 12, 2024

Codexis Strengthens Board with Biotech Veteran Raymond De Vré, Former PolyPeptide CEO | CDXS Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

Biofuel Enzymes Market Growth Surge: Key Players and Market - openPR

Nov 12, 2024

Nov 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics - GlobeNewswire

Nov 11, 2024

Nov 11, 2024

Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for - The Bakersfield Californian

Nov 11, 2024

Nov 11, 2024

Codexis to Showcase Breakthrough RNA Platform, Partners with Bachem at TIDES Europe 2024 | CDXS Stock News - StockTitan

Nov 11, 2024

Nov 08, 2024

Codexis (CDXS) Grants New Employee 50,000 Stock Options, 15,000 RSUs in Equity Package - StockTitan

Nov 08, 2024

Nov 07, 2024

Codexis, Inc.'s (NASDAQ:CDXS) 29% Jump Shows Its Popularity With Investors - Simply Wall St

Nov 07, 2024

Nov 06, 2024

Benchmark Downgrades Codexis (CDXS) - MSN

Nov 06, 2024

Nov 06, 2024

CDXS (Codexis) PE Ratio : At Loss (As of Nov. 06, 2024) - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Codexis (FRA:4QK) 3-Year EBITDA Growth Rate : -26.40% (As of Sep. 2024) - GuruFocus.com

Nov 06, 2024

Nov 06, 2024

Benchmark Reaffirms “Hold” Rating for Codexis (NASDAQ:CDXS) - Defense World

Nov 06, 2024

Nov 06, 2024

Codexis's SWOT analysis: enzyme engineering firm pivots to RNAi stock By Investing.com - Investing.com Australia

Nov 06, 2024